Istari Oncology Inc

Istari Oncology Inc, based in Morrisville, NC, is a pioneering biotechnology company focused on elevating the standard of cancer care through innovative immunotherapy solutions. Their unique immune activator, lerapolturev, leverages the power of the poliovirus to stimulate a potent anticancer immune response, targeting solid tumors and engaging antigen presenting cells for effective T cell activation.

With a strong emphasis on clinical trials and FDA support, Istari Oncology is at the forefront of developing breakthrough therapies for recurrent glioblastoma and advanced melanoma. Their ongoing research and commitment to advancing cancer treatment highlight their dedication to lighting the way toward antitumor immunity.

Generated from the website